|
|
||||||||
Yale University, School of Medicine, New Haven, Connecticut
Correspondence: For reprints contact: Richard P. Spencer, Yale Univ. School of Medicine, Depart. of Radiology, Section of Nuclear Medicine, 333 Cedar St., New Haven, Conn. 06510.
ABSTRACT
Dividing the population receiving radioiodide therapy for hyperthyroidism into two groupings (cured and not cured) leads to quantitative expressions for the results which can be made to agree closely with actual data. A series of linear formulations are presented which may be of use in comparing populations and in testing the validity of proposed theories of the mechanism of action of radioiodide.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |